Mpox clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • Tecovirimat for Human Mpox Virus

    Sorry, in progress, not accepting new patients

    A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.

    San Francisco, California and other locations

Last updated: